title: Glycemic control impact on body weight potential to reduce cardiovascular risk: glucagon-like peptide 1 agonists.
authors.affiliation: Department of Experimental and Clinical Medicine, University of Catanzaro Magna Greacia, Catanzaro, Italy. sesti@unicz.it
authors.forename: Giorgio
authors.initials: G
authors.lastname: Sesti
mesh_terms: D001835:Body Weight / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism; D052216:Glucagon-Like Peptide 1 / Q000819:agonists*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D054795:Incretins / Q000378:metabolism
chemical_list: D007004:Hypoglycemic Agents; D054795:Incretins; D052216:Glucagon-Like Peptide 1